#1 Clinical Trials Search in Europe

Prednisolone Metasulfobenzoate Sodium

This article summarizes several clinical trials investigating the use of prednisolone metasulfobenzoate sodium, a corticosteroid medication, for treating different medical conditions. The trials explore its effectiveness in managing ulcerative colitis, asthma exacerbations, infantile hemangiomas, and oral lichen planus. Researchers are examining various formulations and dosing regimens to optimize treatment outcomes while minimizing side effects.

Table of Contents

What is Prednisolone Metasulfobenzoate Sodium?

Prednisolone Metasulfobenzoate Sodium is a type of medication known as a corticosteroid or steroid. It’s a synthetic version of hormones naturally produced by your adrenal glands. This medication is used to treat various inflammatory conditions and autoimmune disorders[1]. Prednisolone Metasulfobenzoate Sodium is also known by other names, including:

  • Prednisolone
  • Prednisolone Sodium Phosphate
  • Corticosteroids

These different names may be used interchangeably in medical contexts, but they all refer to the same type of medication[1][2].

Conditions Treated with Prednisolone

Prednisolone is used to treat a wide range of conditions characterized by inflammation or overactivity of the immune system. Some of the conditions that may be treated with prednisolone include:

  • Asthma: Prednisolone is used to treat severe asthma exacerbations in hospitalized patients[2].
  • Ulcerative Colitis: This is a type of inflammatory bowel disease that causes inflammation in the large intestine. Prednisolone may be used to treat moderate acute cases[3].
  • Infantile Hemangiomas: These are benign tumors made of blood vessels that can appear in infants. Prednisolone may be used for treatment in some cases[4].
  • Erosive Oral Lichen Planus: This is a chronic inflammatory condition affecting the mucous membranes in the mouth. Prednisolone may be used as a treatment option[1].

How is Prednisolone Administered?

Prednisolone can be administered in various forms, depending on the condition being treated and the patient’s needs. Some common forms include:

  • Oral tablets or capsules: These are taken by mouth, usually once daily in the morning[1].
  • Oral suspension: This liquid form is often used for children or adults who have difficulty swallowing tablets[4].
  • Intravenous (IV) infusion: In some cases, especially for severe conditions in hospitalized patients, prednisolone may be given through an IV[2].
  • Eye drops: For certain eye conditions, prednisolone may be administered as eye drops[5].

Dosage Information

The dosage of prednisolone can vary widely depending on the condition being treated, the severity of the condition, and individual patient factors. Here are some examples of dosages used in clinical trials:

  • For severe asthma exacerbations: 40 mg per day for 10 days[2].
  • For erosive oral lichen planus: 40 mg once daily in the morning for one month, followed by a tapering dose over the next month[1].
  • For infantile hemangiomas: Starting daily dose of 2.5 mg/kg[4].

It’s important to note that these are examples from specific studies, and your doctor will prescribe the appropriate dosage for your individual situation. Never adjust your dosage without consulting your healthcare provider.

Potential Side Effects

Like all medications, prednisolone can cause side effects. Some potential side effects include:

  • Increased risk of infections
  • Changes in blood sugar levels
  • Changes in blood pressure
  • Mood changes
  • Weight gain
  • Osteoporosis (with long-term use)

In children, there’s a concern about potential effects on the immune system and growth[4]. Your doctor will monitor you closely for any side effects and adjust your treatment as necessary.

Ongoing Research and Clinical Trials

Researchers continue to study prednisolone to better understand its effects and explore new uses. Some areas of ongoing research include:

  • Comparing oral prednisolone to intravenous methylprednisolone for treating severe asthma exacerbations[2].
  • Investigating a new formulation called COLAL-PRED® for treating ulcerative colitis[3].
  • Studying the effects of prednisolone on the immune system in infants treated for hemangiomas[4].
  • Exploring the use of liposomal prednisolone to improve hemodialysis fistula maturation[6].

These ongoing studies help doctors better understand how to use prednisolone effectively and safely for various conditions.

Condition Formulation Dosage Key Outcomes Measured
Ulcerative Colitis COLAL-PRED® oral capsules 40, 60, or 80 mg daily for 8 weeks Disease activity index, clinical colitis activity index
Asthma Exacerbation Oral suspension 1 mg/kg/day for 3 days Length of hospital stay, PEWS score, recurrence of wheezing
Infantile Hemangioma Oral suspension 2.5 mg/kg daily, tapered over time Lymphocyte count, immune system function
Oral Lichen Planus Oral tablets 40 mg daily, tapered over 2 months Pain (VAS score), lesion size (Thongprasom scoring index)

FAQ

  • What conditions are being studied with prednisolone metasulfobenzoate sodium? The clinical trials are investigating prednisolone metasulfobenzoate sodium for treating ulcerative colitis, asthma exacerbations, infantile hemangiomas, and oral lichen planus.
  • How is prednisolone metasulfobenzoate sodium administered in these trials? The medication is administered in various forms, including oral capsules, oral suspensions, and intravenous infusions. The dosage and duration vary depending on the condition being treated and the specific trial protocol.
  • What are some potential benefits of using prednisolone metasulfobenzoate sodium? Potential benefits include reducing inflammation, improving symptoms in conditions like ulcerative colitis and asthma, promoting healing of infantile hemangiomas, and managing pain and lesions in oral lichen planus.
  • Are there any special formulations of prednisolone being studied? Yes, one trial is investigating a novel dosage form called COLAL-PRED® for ulcerative colitis treatment. Another study is exploring liposomal prednisolone for improving hemodialysis fistula maturation.
  • How do researchers measure the effectiveness of prednisolone metasulfobenzoate sodium in these trials? Researchers use various measures to assess effectiveness, including disease activity indexes, symptom scores, physical examinations, laboratory tests, and patient-reported outcomes. They also monitor for side effects and compare results to placebo or standard treatments.

Ongoing Clinical Trials on Prednisolone Metasulfobenzoate Sodium

  • Study of N-acetylcysteine and prednisolone combination versus extended prednisolone treatment in patients with severe alcoholic hepatitis

    Recruiting

    1 1 1
    Investigated drugs:
    France

  • Study on Reducing Tacrolimus in Kidney Transplant Patients with Low Immunological Risk Using Tacrolimus, Mycophenolic Acid, and Prednisone

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Norway Spain

  • Study on Sirolimus and Prednisolone for Treating Superficial Arteriovenous Malformations in Patients

    Not yet recruiting

    1 1 1
    Investigated drugs:
    France

  • Study on High-Dose Methylprednisolone and Prednisolone for Children with Stroke Due to Focal Cerebral Arteriopathy

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    Austria Denmark France Germany Sweden

Glossary

  • Prednisolone metasulfobenzoate sodium: A corticosteroid medication used to reduce inflammation and suppress the immune system in various medical conditions.
  • Ulcerative colitis: A chronic inflammatory bowel disease that causes inflammation and ulcers in the digestive tract, primarily affecting the large intestine and rectum.
  • Asthma exacerbation: A worsening of asthma symptoms, such as shortness of breath, wheezing, and coughing, which may require additional treatment or hospitalization.
  • Infantile hemangioma: A benign tumor of blood vessels that appears in infancy, often as a red birthmark that can grow rapidly in the first few months of life.
  • Oral lichen planus: A chronic inflammatory condition that affects the mucous membranes of the mouth, causing white, lacy patches, redness, and sometimes painful sores.
  • COLAL-PRED®: A novel dosage form of prednisolone ester being studied for the treatment of ulcerative colitis.
  • Liposomal prednisolone: A formulation of prednisolone encapsulated in liposomes, which may allow for targeted delivery and reduced systemic side effects.
  • Corticosteroid: A class of steroid hormones produced in the adrenal cortex or synthesized artificially, used to treat various inflammatory and autoimmune conditions.
  • Disease activity index: A measure used to assess the severity and progression of a disease, often combining multiple clinical and laboratory parameters.
  • Placebo: An inactive substance or treatment used in clinical trials as a control to compare against the effects of the active drug or intervention being studied.

References

  1. https://clinicaltrials.gov/study/NCT04652739
  2. https://clinicaltrials.gov/study/NCT00627731
  3. https://clinicaltrials.gov/study/NCT00299013
  4. https://clinicaltrials.gov/study/NCT00433940
  5. https://clinicaltrials.gov/study/NCT02028754
  6. https://clinicaltrials.gov/study/NCT02495662